n-methyl-3,4-methylenedioxyamphetamine has been researched along with Affective Disorders in 5 studies
N-Methyl-3,4-methylenedioxyamphetamine: An N-substituted amphetamine analog. It is a widely abused drug classified as a hallucinogen and causes marked, long-lasting changes in brain serotonergic systems. It is commonly referred to as MDMA or ecstasy.
3,4-methylenedioxymethamphetamine : A member of the class of benzodioxoles that is 1,3-benzodioxole substituted by a 2-(methylamino)propyl group at position 5.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Martín-Santos, R | 1 |
| Torrens, M | 1 |
| Poudevida, S | 1 |
| Langohr, K | 1 |
| Cuyás, E | 1 |
| Pacifici, R | 1 |
| Farré, M | 1 |
| Pichini, S | 1 |
| de la Torre, R | 1 |
| de Win, MM | 1 |
| Reneman, L | 1 |
| Reitsma, JB | 1 |
| den Heeten, GJ | 1 |
| Booij, J | 1 |
| van den Brink, W | 1 |
| Thomasius, R | 1 |
| Petersen, KU | 1 |
| Zapletalova, P | 1 |
| Wartberg, L | 1 |
| Zeichner, D | 1 |
| Schmoldt, A | 1 |
| Baylen, CA | 1 |
| Rosenberg, H | 1 |
| Milroy, CM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neurotoxicity of Ecstasy: Causality, Course and Clinical Relevance[NCT00235768] | 225 participants | Observational | 2002-04-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for n-methyl-3,4-methylenedioxyamphetamine and Affective Disorders
| Article | Year |
|---|---|
A review of the acute subjective effects of MDMA/ecstasy.
Topics: Adolescent; Adult; Aged; Cognition; Cognition Disorders; Emotions; Female; Hallucinogens; Humans; Il | 2006 |
Ten years of 'ecstasy'.
Topics: Adolescent; Adult; Female; Heat Stroke; History, 20th Century; Humans; Illicit Drugs; Liver Failure; | 1999 |
3 other studies available for n-methyl-3,4-methylenedioxyamphetamine and Affective Disorders
| Article | Year |
|---|---|
5-HTTLPR polymorphism, mood disorders and MDMA use in a 3-year follow-up study.
Topics: Adolescent; Adult; Alleles; Amphetamine-Related Disorders; Comorbidity; Cross-Sectional Studies; Fem | 2010 |
Mood disorders and serotonin transporter density in ecstasy users--the influence of long-term abstention, dose, and gender.
Topics: Adolescent; Adult; Brain; Female; Humans; Male; Membrane Glycoproteins; Membrane Transport Proteins; | 2004 |
Mental disorders in current and former heavy ecstasy (MDMA) users.
Topics: Adult; Amphetamine-Related Disorders; Anxiety Disorders; Cognition Disorders; Cross-Sectional Studie | 2005 |